LI MA and JEFFREY TYNER were named the recipients of the American Association for the Advancement of Science’s Martin and Rose Wachtel Cancer Research Award.
The award honors investigators who have performed outstanding work in the field of cancer research, and have received their Ph.D. or M.D. within the last 10 years.
Tyner and Ma’s award entry essays were published in the July 2 edition of Science Translational Medicine. Both will deliver public lectures on their research July 7 at an event co-hosted by the NCI Center for Cancer Research at the NIH Lipsett Amphitheater in Bethesda, Md. They will split the award of $25,000.
Ma is an assistant professor of experimental radiation oncology at MD Anderson Cancer Center. Tyner is an assistant professor of cell, developmental and cancer biology at the Oregon Health and Science University.
Ma’s research focuses on regulating breast cancer metastasis, breast tumor radioresistance, and key breast cancer proteins and pathways. Tyner helped develop a research program that more rapidly identifies the mutations driving a patient’s cancer and accelerates development of precision treatments.
JOHN CLEVELAND was named associate center director of basic science at Moffitt Cancer Center.
Cleveland comes to Moffitt from the Scripps Florida campus of The Scripps Research Institute, where he served nearly eight years as a professor and chair of the Department of Cancer Biology. Prior to that, he spent more than 17 years at St. Jude Children’s Research Hospital. He also completed a fellowship and senior fellowship at NCI.
He currently serves as a member of the Extramural Scientific Advisory Board for the Gastrointestinal SPORE programs at the University of Arizona and the Blood Research Institute of Wisconsin. He has served as editor for numerous scientific journals and has been a long-serving member and ad-hoc reviewer for NIH R01 Grant Program and Project Grant Review Committees.
THE COMMUNITY ONCOLOGY ALLIANCE appointed new officers. Bruce Gould, of Northwest Georgia Oncology Centers in Marietta, Ga., was named president of COA.
Jeff Vacirca, of North Shore Hematology Oncology Associates in East Setauket, N.Y., was named vice-president; Michael Diaz, of Florida Cancer Specialists and Research Institute in Tampa, Fla., was named secretary; and Ricky Newton, of Cancer Specialists of Tidewater in Chesapeake, Va, was named treasurer.
The COA’s immediate past president is Mark Thompson, of The Zangmeister Center in Columbus, Ohio, who will continue to serve as chairman of the COA Payment Reform Task Force and legislative liaison on congressional matters. Past President David Eagle, of Lake Norman Hematology Oncology in Charlotte, N.C., will assume the position of chairman of the Oncology Medical Home Steering Committee.
ROSWELL PARK CANCER INSTITUTE received an “outstanding” distinction from NCI, which renewed its Cancer Center Support Grant and extended its Comprehensive Cancer Center designation, following an in-depth peer review. Roswell Park will receive $19 million with the core grant covering a five-year period.
“With this renewal comes recognition from our peers from cancer centers around the nation of Roswell Park’s excellence in conducting innovative research, distinguished education programs and exemplary patient care,” said RPCI President and CEO Donald Trump.
The panel of peer reviewers from other NCI-designated centers wrote: “Under the exemplary leadership of the Center Director and with the continued involvement of the outstanding and productive Senior Leaders and commitment of the Institution… this established Cancer Center is well positioned to continue its contributions to the national mission to understand and eliminate cancer.”
New York State Governor Andrew Cuomo and Congressman Brian Higgins, along with other state and local leaders, joined Trump for Tuesday’s announcement at the 116-year-old cancer center.
THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY has named 30 society members to receive the Fellow of ASTRO designation. The 2014 class will receive the recognition during an awards ceremony Sept. 16 at the society’s annual meeting in San Francisco.
The Fellows Program honors radiation oncology leaders who have been an ASTRO member for at least 15 years, who have contributed the equivalent of 10 years of service to ASTRO and who have made substantial contributions to the field of radiation oncology in the areas of research, education, patient care or service, and leadership. Including this year’s class, 242 of more than 10,000 members worldwide have received the FASTRO designation.
The members of the 2014 Fellows class are:
• John Buatti, chair of and professor in the Department of Radiation Oncology of the University of Iowa
• Thomas Delaney, medical director of the Francis H. Burr Proton Therapy Center, co-director of the Center for Sarcoma and Connective Tissue Oncology and a radiation oncologist at Massachusetts General Hospital
• Adam Dicker, chair of the Department of Radiation Oncology at Thomas Jefferson University
• Avraham Eisbruch, the Newman Family Professor of Radiation Oncology, at the University of Michigan
• Eduardo Fernandez, senior vice-president of medical affairs and medical director for Latin America at 21st Century Oncology
• David Gaffney, medical director of the Radiation Oncology Clinic and vice-chair of and professor in the Department of Radiation Oncology at the Huntsman Cancer Institute and University of Utah
• Adam Garden, associate medical director of the Head and Neck Center and professor of radiation oncology at MD Anderson Cancer Center
• Katherine Griem, professor of radiation oncology at Rush University Medical Center
• William Hartsell, medical director of the CDH Proton Center
• James Alan Hayman, associate chair for clinical activities and professor of radiation oncology at the University of Michigan
• I-Chow Hsu, vice-chair of and professor in the Department of Radiation Oncology, at the University of California, San Francisco
• Lisa Kachnic, chair of the Department of Radiation Oncology at Boston Medical Center
• Brian Kavanagh, vice-chair and clinical practice director of and professor in the Department of Radiation Oncology at the University of Colorado
• Timothy Kinsella, research scholar professor in the Department of Radiation Oncology at Warren Alpert Medical School
• Andre Konski, clinical professor in the Department of Radiation Oncology at the University of Pennsylvania
• Patrick Kupelian, vice-chair of clinical operations and clinical research and professor of radiation oncology at University of California, Los Angeles
• Quynh-Thu Le, chair of the Department of Radiation Oncology and the Katherine Dexter McCormick and Stanley McCormick Memorial Professor at Stanford University
• W. Robert Lee, professor of radiation oncology at Duke University School of Medicine
• Stephen Lutz, attending radiation oncologist at Blanchard Valley Regional Cancer Center
• C.M. Charlie Ma, vice-chair of the Department of Radiation Oncology and director and professor of medical physics at Fox Chase Cancer Center
• Bruce Minsky, deputy division head, director of clinical research, Frank T. McGraw Memorial Chair in the Study of Cancer and professor in the Division of Radiation Oncology at MD Anderson Cancer Center
• Najeeb Mohideen, attending radiation oncologist at Northwest Community Hospital
• Simon Powell, chair of the Department of Radiation Oncology and the Enid A. Haupt Chair in Radiation Oncology at Memorial Sloan Kettering Cancer Center
• Mack Roach III, chair of and professor in the Department of Radiation Oncology, at the University of California, San Francisco
• Kenneth Rosenzweig, chair of and professor in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai
• Christopher Schultz, professor of radiation oncology at the Medical College of Wisconsin
• Dennis Shrieve, chair of the Department of Radiation Oncology and the Rudolph P. and Edna S. Reese Research Professor in Radiation Oncology at the University of Utah
• Paul Sperduto, co-director of the Gamma Knife Center, University of Minnesota, Minneapolis, and radiation oncologist, at Minneapolis Radiation Oncology
• Maria Werner-Wasik, director of clinical research and professor in the Department of Radiation Oncology, at Thomas Jefferson University
• Jeffrey Williamson, professor of medical physics, Virginia Commonwealth University Medical Center